292 related articles for article (PubMed ID: 16509932)
1. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.
Galesic K; Bozic B; Racic I; Scukanec-Spoljar M
Nephrology (Carlton); 2006 Feb; 11(1):49-52. PubMed ID: 16509932
[TBL] [Abstract][Full Text] [Related]
2. Withdrawal of interferon-alpha results in prompt resolution of thrombocytopenia and hemolysis but not renal failure in hemolytic uremic syndrome caused by interferon-alpha.
Ohashi N; Yonemura K; Sugiura T; Isozaki T; Togawa A; Fujigaki Y; Yamamoto T; Hishida A
Am J Kidney Dis; 2003 Mar; 41(3):E10. PubMed ID: 12613003
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: coincidence or true side effect?
Ravandi-Kashani F; Cortes J; Talpaz M; Kantarjian HM
Cancer; 1999 Jun; 85(12):2583-8. PubMed ID: 10375106
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myelocytic leukemia.
Honda K; Ando A; Endo M; Shimizu K; Higashihara M; Nitta K; Nihei H
Am J Kidney Dis; 1997 Jul; 30(1):123-30. PubMed ID: 9214412
[TBL] [Abstract][Full Text] [Related]
5. Nephrotic syndrome associated with alpha interferon therapy in chronic myeloid leukemia.
Budak-Alpdoğan T; Lawrence RA; Bayik M; Akoğlu E
Clin Nephrol; 1997 Jul; 48(1):59-60. PubMed ID: 9247783
[No Abstract] [Full Text] [Related]
6. Renal thrombotic microangiopathy associated with interferon-alpha treatment of chronic myeloid leukemia.
Magee CC; Abraham K; Farrell J; Dorman T; Walshe JJ
Am J Kidney Dis; 2000 Jul; 36(1):E5. PubMed ID: 10873904
[TBL] [Abstract][Full Text] [Related]
7. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.
Bremer CT; Lastrapes A; Alper AB; Mudad R
Am J Clin Oncol; 2003 Jun; 26(3):262-4. PubMed ID: 12796597
[TBL] [Abstract][Full Text] [Related]
8. [Occurrence of autoimmune complications in patients with chronic myelocytic leukemia during treatment with interferon alfa].
Tóthová E; Stecová N; Kafková A; Fricová M; Svorcová E
Vnitr Lek; 2002 May; 48(5):380-3. PubMed ID: 12061203
[TBL] [Abstract][Full Text] [Related]
9. [Hemolytic uremic syndrome-like episode following nonmyeloablative hematopoietic stem cell transplantation in a patient with chronic myeloid leukemia].
Takahashi N; Miura I; Kume M; Kawabata Y; Hirokawa M; Sawada K
Rinsho Ketsueki; 2003 Jun; 44(6):391-5. PubMed ID: 12884818
[TBL] [Abstract][Full Text] [Related]
10. Interferon alpha sensitisation induced fatal renal insufficiency in a patient with chronic myeloid leukaemia: case report and review of literature.
Colovic M; Jurisic V; Jankovic G; Jovanovic D; Nikolic LJ; Dimitrijevic J
J Clin Pathol; 2006 Aug; 59(8):879-81. PubMed ID: 16873566
[TBL] [Abstract][Full Text] [Related]
11. [Treatment with lymphoblastoid alpha interferon in patients with chronic myeloid leukemia refractory to recombinant interferon alpha 2].
Steegmann JL; Granados E; Vázquez L; de la Cámara R; Peñarrubia MJ; Fernández-Contreras E; Quiroga JA; Fernández Rañada JM
Sangre (Barc); 1998 Oct; 43(5):443-6. PubMed ID: 9868341
[TBL] [Abstract][Full Text] [Related]
12. [Chronic myelogenous leukemia with long-term hypoplasia induced by alpha-interferon and hydroxyurea].
Motomura S; Sakai R; Tomita N; Fujimaki K; Hattori M; Fujisawa S; Mohri H; Takahashi N; Maruta A; Kodama F; Okubo T
Rinsho Ketsueki; 1998 Apr; 39(4):302-7. PubMed ID: 9597898
[TBL] [Abstract][Full Text] [Related]
13. [Alpha interferon in children with Philadelphia chromosome-positive chronic myeloid-leukaemia].
Ben Lakhal R; Aissaoui L; Jeddi R; Ayari B; Ben Abid H; Belhadj Ali Z; Gouider E; Meddeb B; Hafsia R; Hafsia A
Tunis Med; 2005 May; 83(5):296-9. PubMed ID: 16044905
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of chronic myeloid leukemia with interferon-alpha].
Szomor A; Molnár L; Nagy A; Dávid M; Alizadeh H; Kecskés M; Vidra T; Kereskai L; Pajor L; Losonczy H
Orv Hetil; 2000 Nov; 141(48):2601-4. PubMed ID: 11141958
[TBL] [Abstract][Full Text] [Related]
15. A kidney biopsy is clearly mandatory to confirm the indication of plasma exchanges in adult haemolytic uraemic syndrome.
Pourrat O; Touchard G; Robert R; Badia P; Bauwens M; Hauet T; Patte D
Ann Med Interne (Paris); 1994; 145(5):369-72. PubMed ID: 7985952
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy.
Shah M; Jenis EH; Mookerjee BK; Schriber JR; Baer MR; Herzig GP; Wetzler M
Cancer; 1998 Nov; 83(9):1938-46. PubMed ID: 9806652
[TBL] [Abstract][Full Text] [Related]
17. Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature.
Vaiopoulos G; Terpos E; Viniou N; Nodaros K; Rombos J; Loukopoulos D
Am J Hematol; 2001 Jan; 66(1):57-8. PubMed ID: 11426495
[TBL] [Abstract][Full Text] [Related]
18. The role of interferon-alpha in the treatment of chronic myeloid leukemia.
Kujawski LA; Talpaz M
Cytokine Growth Factor Rev; 2007; 18(5-6):459-71. PubMed ID: 17703986
[TBL] [Abstract][Full Text] [Related]
19. Lymphoid blast crisis during interferon-alpha therapy in a patient with chronic myelogenous leukemia in myeloid blast crisis.
Goto H; Tsurumi H; Hara T; Moriwaki H
Int J Hematol; 2000 Dec; 72(4):474-6. PubMed ID: 11197215
[TBL] [Abstract][Full Text] [Related]
20. Achievement of complete molecular responses in late chronic phase chronic myeloid leukaemia patients treated with pulsed imatinib while in minimal residual disease.
Breccia M; Cannella L; Stefanizzi C; Santopietro M; De Cuia R; Diverio D; Alimena G
Leuk Res; 2009 May; 33(5):645-8. PubMed ID: 19062090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
